UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 199

Sortiert nach

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

PloS one, 2022-09, Vol.17 (9), p.e0275254

2022

Volltextzugriff (PDF)

Cobicistat as a Pharmacoenhancer in Pregnancy and Postpartum: Progress to Date and Next Steps

Journal of clinical pharmacology, 2019-06, Vol.59 (6), p.779-783

2019

Volltextzugriff (PDF)

Praziquantel for the treatment of schistosomiasis during human pregnancy

Bulletin of the World Health Organization, 2018-01, Vol.96 (1), p.59-65

2018

Volltextzugriff (PDF)

Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir

Journal of clinical pharmacology, 2020-02, Vol.60 (2), p.240-255

2020

Volltextzugriff (PDF)

Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum

Antimicrobial agents and chemotherapy, 2020-08, Vol.64 (9)

2020

Volltextzugriff (PDF)

Pharmacokinetics of antiretrovirals in pregnant women

Clinical pharmacokinetics, 2004-01, Vol.43 (15), p.1071-1087

2004

Volltextzugriff (PDF)

Antiretroviral Concentrations in Breast-Feeding Infants of Mothers Receiving Highly Active Antiretroviral Therapy

Antimicrobial Agents and Chemotherapy, 2009-03, Vol.53 (3), p.1170-1176

2009

Volltextzugriff (PDF)

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

PloS one, 2022-09, Vol.17 (9)

2022

Volltextzugriff (PDF)

Determination of Benznidazole in Human Dried Blood Spots by Liquid Chromatography-Mass Spectrometry to Monitor Adherence to Trypanosoma cruzi Infection Treatment in Infants and Children

The American journal of tropical medicine and hygiene, 2019-01, Vol.101 (1), p.116-122

2019

Volltextzugriff (PDF)

Physiologically‐based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID‐19

CPT: pharmacometrics and systems pharmacology, 2023-02, Vol.12 (2), p.148-153

2023

Volltextzugriff (PDF)

Raltegravir pharmacokinetics in neonates following maternal dosing

Journal of acquired immune deficiency syndromes (1999), 2014-11, Vol.67 (3), p.310

2014

Volltextzugriff (PDF)

Oseltamivir pharmacokinetics in pregnancy: a commentary

American journal of obstetrics and gynecology, 2011-06, Vol.204 (6), p.S94-S95

2011

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants

Antimicrobial Agents and Chemotherapy, 2011-12, Vol.55 (12), p.5914-5922

2011

Volltextzugriff (PDF)

Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

CPT: pharmacometrics and systems pharmacology, 2019-09, Vol.8 (9), p.643-653

2019

Volltextzugriff (PDF)

Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development

Frontiers in pediatrics, 2021-10, Vol.9, p.721059-721059

2021

Volltextzugriff (PDF)

Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV

The New England journal of medicine, 2023-01, Vol.388 (4), p.344-356

2023

Volltextzugriff (PDF)

Targeted Echocardiography in the Neonatal Intensive Care Unit

Journal of the American Society of Echocardiography, 2012-03, Vol.25 (3), p.361-361

2012

Volltextzugriff (PDF)

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial

The Lancet (British edition), 2021-04, Vol.397 (10281), p.1276-1292

2021

Volltextzugriff (PDF)

Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus

Clinical infectious diseases, 2019-09, Vol.69 (7), p.1254-1258

2019

Volltextzugriff (PDF)

Antiretroviral Pharmacology: Special Issues Regarding Pregnant Women and Neonates

Clinics in perinatology, 2010-12, Vol.37 (4), p.907-927

2010

Volltextzugriff (PDF)

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women

Frontiers in pharmacology, 2016-08, Vol.7, p.239-239

2016

Volltextzugriff (PDF)

Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents

Clinical infectious diseases, 2022-11, Vol.75 (Suppl 4), p.S562-S570

2022

Volltextzugriff (PDF)

Population Pharmacokinetics of Lamivudine in Human Immunodeficiency Virus-Exposed and -Infected Infants

Antimicrobial Agents and Chemotherapy, 2007-12, Vol.51 (12), p.4297-4302

2007

Volltextzugriff (PDF)

Ritonavir and cobicistat as pharmacokinetic enhancers in pregnant women

Expert opinion on drug metabolism & toxicology, 2019-07, Vol.15 (7), p.523-525

2019

Volltextzugriff (PDF)

1 – 25 von 199

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(194)
Mit Volltextzugriff
(150)

Publikationsform

Artikel
(197)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(158)
Life Sciences & Biomedicine
(155)
Humans
(145)
Female
(131)
Pregnancy
(115)
Infectious Diseases
(95)
Hiv Infections - Drug Therapy
(90)
Infant, Newborn
(74)
Immunology
(71)
Hiv
(66)
Adult
(65)
Pharmacokinetics
(62)
Biological And Medical Sciences
(60)
Medical Sciences
(60)
Pregnancy Complications, Infectious - Drug Therapy
(55)
Human Immunodeficiency Virus
(51)
Infant
(48)
Anti-Hiv Agents - Pharmacokinetics
(47)
Antiretroviral Drugs
(45)
Pharmacology & Pharmacy
(41)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

Cobicistat as a Pharmacoenhancer in Pregnancy and Postpartum: Progress to Date and Next Steps

Praziquantel for the treatment of schistosomiasis during human pregnancy

Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir

Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum

Pharmacokinetics of antiretrovirals in pregnant women

Combined evaluation of sexually transmitted infections in HIV-infected pregnant women and infant HIV transmission

Antiretroviral Concentrations in Breast-Feeding Infants of Mothers Receiving Highly Active Antiretroviral Therapy

Assessment of minority frequency pretreatment HIV drug-resistant variants in pregnant women and associations with virologic non-suppression at term

Determination of Benznidazole in Human Dried Blood Spots by Liquid Chromatography-Mass Spectrometry to Monitor Adherence to Trypanosoma cruzi Infection Treatment in Infants and Children

Physiologically‐based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID‐19

Raltegravir pharmacokinetics in neonates following maternal dosing

Oseltamivir pharmacokinetics in pregnancy: a commentary

Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants

Maternal–Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development

Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV

Targeted Echocardiography in the Neonatal Intensive Care Unit

Importance of Prospective Studies in Pregnant and Breastfeeding Women Living With Human Immunodeficiency Virus

Antiretroviral Pharmacology: Special Issues Regarding Pregnant Women and Neonates

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women

Potential of Long-Acting Products to Transform the Treatment and Prevention of Human Immunodeficiency Virus (HIV) in Infants, Children, and Adolescents

Population Pharmacokinetics of Lamivudine in Human Immunodeficiency Virus-Exposed and -Infected Infants

Ritonavir and cobicistat as pharmacokinetic enhancers in pregnant women

Suchergebnisse filtern